¼¼°èÀÇ Àå±â º¸Á¸ ¿ë¾× ½ÃÀå º¸°í¼­(2025³â)
Organ Preservation Solution Global Market Report 2025
»óǰÄÚµå : 1776046
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,324,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,141,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,958,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àå±â º¸Á¸ ¿ë¾× ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 6.7%·Î 4¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº È®´ëµÈ ±âÁØÀÇ Àå±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Àå±â Á¶´Þ ÇÁ·Î±×·¥ÀÇ È®´ë, Àå±âÀÇ Ç°Áú°ú ±â´É¼º¿¡ ´ëÇÑ °­Á¶, Àå±â ºÎÁ·¿¡ ´ëóÇϱâ À§ÇÑ Àü ¼¼°èÀûÀÎ ³ë·Â¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Àå±â ÀºÇàÀÇ º¸Á¸ ¿ë¾× Àû¿ë, º¸Á¸ ½Ã°£ ¿¬Àå¿¡ ´ëÇÑ ½ÃÀåÀÇ ÁýÁß, º¸Á¸ °­È­¸¦ À§ÇÑ Ã·°¡Á¦ ÅëÇÕ, ÈÞ´ë¿ë ¹× ¼ÒÇü Àå±â º¸Á¸ ÀåÄ¡¿¡ ´ëÇÑ ÁýÁß, Àå±â º¸Á¸ ¿¬±¸ ¹× ±â¼ú Çõ½ÅÀ» À§ÇÑ Çù·Â µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

ÇâÈÄ 5³â°£ 6.7%ÀÇ ¼ºÀå·ü Àü¸ÁÀº Áö³­¹ø ¿¹Ãø¿¡¼­ 0.3%ÀÇ ¼ÒÆø ÇÏÇâ Á¶Á¤µÈ ¼öÄ¡ÀÔ´Ï´Ù. ÀÌ °¨¼Ò´Â ÁÖ·Î ¹Ì±¹°ú ´Ù¸¥ ±¹°¡ °£ÀÇ °ü¼¼ÀÇ ¿µÇâ¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ´Â º§±â¿¡¿Í ½º¿þµ§À¸·ÎºÎÅÍÀÇ Áß¿äÇÑ ¼öÀÔǰÀÎ ÀÌ½Ä ¼Ö·ç¼ÇÀÇ ÀÇ·á °ø±Þ¸ÁÀ» ¹æÇØÇϰí ÀÇ·á ºñ¿ëÀ» »ó½Â½ÃÅ´À¸·Î½á ¹Ì±¹¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¶ÇÇÑ, »óÈ£ °ü¼¼¿Í ¹«¿ª ±äÀå °íÁ¶ ¹× Á¦ÇÑÀ¸·Î ÀÎÇÑ ¼¼°è °æÁ¦¿Í ¹«¿ª¿¡ ´ëÇÑ ¾Ç¿µÇâÀ¸·Î ÀÎÇØ ±× ¿µÇâÀº ´õ¿í ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³¯ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Organ preservation solutions are specially formulated solutions designed for the preservation of organs during transplantation or storage. These solutions play a crucial role in safeguarding organs from potential damage during the transplantation process and extending the period for which organs can be stored outside of the body. Organ preservation solutions are formulated with specific agents that aim to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.

There are several main types of organ preservation solutions, including Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan, for example, is utilized for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys. It plays a crucial role in maintaining organ viability during transportation and before transplantation. These solutions are employed in preserving various organs, including kidneys, liver, lungs, hearts, and others, utilizing techniques such as static cold storage (SCS) and hypothermic machine perfusion. These preservation techniques are essential for ensuring the successful transplantation of organs and improving overall patient outcomes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The escalating U.S. tariffs and rising trade tensions in spring 2025 are expected to significantly affect the chemicals sector, which is facing a disproportionate impact-particularly from tariffs on petrochemicals and intermediates, where affordable domestic alternatives are limited. Specialty chemical producers, who rely heavily on Chinese raw materials, are encountering production disruptions. Meanwhile, fertilizer manufacturers are seeing their profit margins squeezed due to tariffs on phosphate imports. In response, companies are increasing investments in R&D for bio-based alternatives, forming procurement alliances to strengthen purchasing power, and relocating production to tariff-neutral countries like Saudi Arabia.

The organ preservation solution research report is one of a series of new reports from The Business Research Company that provides organ preservation solution market statistics, including the organ preservation solution industry's global market size, regional shares, competitors with an organ preservation solution market share, detailed organ preservation solution market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. This organ preservation solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The organ preservation solution market size has grown strongly in recent years. It will grow from $0.29 billion in 2024 to $0.31 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to a rise in organ transplants, growing awareness of organ donation, expansion of healthcare infrastructure, and increasing incidence of organ failure.

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $0.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising demand for extended criteria organs, expansion of organ procurement programs, focus on organ quality and functionality, and global initiatives to address organ shortage. Major trends in the forecast period include the application of preservation solutions in organ banking, market emphasis on extended preservation times, integration of additives for enhanced preservation, focus on portable and compact organ preservation devices, and collaborations for research and innovation in organ preservation.

The forecast of 6.7% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by disrupting medical supply chains for transplant solutions, as critical imports come from Belgium and Sweden, raising healthcare costs.

The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in organ transplantation is poised to drive the growth of the organ preservation solution market in the coming years. Organ transplantation, a surgical procedure involving the extraction and transfer of organs or tissues from a donor to a recipient, relies on organ preservation solutions to mitigate damage during transportation and storage, thereby enhancing organ viability for successful transplantation. For instance, data from the Organ Procurement and Transplantation Network (OPTN) in January 2023 revealed a 3.7 percent increase in organ transplants in 2022, totaling 42,887 procedures compared to 41,354 in 2021. Kidney transplants, constituting a significant share with 25,000 procedures, exhibited a 3.4 percent growth in the United States. Consequently, the upswing in organ transplantation is a key driver for the organ preservation solution market.

The growth of the organ preservation solution market is being propelled by rising healthcare spending. This term refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending employs organ preservation solutions to enhance the success rates of organ transplantation procedures. These solutions are essential for preserving organs during transportation and storage, ensuring their viability for transplantation. Investing in organ preservation solutions leads to improved outcomes for organ transplants, which in turn can reduce the need for additional transplantations and lower associated healthcare costs. For instance, in November 2023, the Canadian Institute for Health Information, a Canada-based organization, projected that total health spending in Canada would reach $344 billion in 2023, which amounts to $8,740 per person. This represents a 2.8% increase compared to the previous year, which saw a growth rate of only 1.5% in 2022, highlighting a significant rebound in healthcare investment. Therefore, the increase in healthcare spending is driving the growth of the organ preservation solution market in the coming years.

Product innovation is a significant trend gaining traction in the organ preservation solution market. Leading companies in this sector are concentrating on developing cutting-edge products to enhance their position and secure a competitive edge. For example, in June 2024, Paragonix Technologies, a US-based firm specializing in organ preservation technology, introduced the PancreasPak Organ Preservation System. This device is the first to receive FDA clearance specifically designed to protect and monitor donor pancreases during transportation, underscoring its crucial role in organ transplantation. The system creates a controlled environment that maintains the pancreas at an optimal thermal range of 4-8°C, which is vital for preserving the organ's viability and functionality during transport, which can last up to 21 hours. The PancreasPak is also equipped with digital monitoring capabilities that continuously track the temperature and surrounding conditions of the pancreas. This real-time data facilitates immediate action in response to any deviations from optimal conditions, thereby enhancing organ preservation.

Moreover, major companies in the organ preservation solution market are actively pursuing technological advancements, particularly in the realm of organ tracking technology, as a strategic move to enhance their competitive standing in organ transportation. Organ tracking technology involves a spectrum of tools and systems dedicated to monitoring the location and condition of organs during transit. In October 2022, Paragonix Technologies Inc. unveiled its VantagePoint organ tracking technology, providing real-time tracking capabilities for donor organs in transit. This technology aims to enhance transparency and accountability in donor organ transportation, augmenting the digital tracking capabilities offered by the Paragonix App.

In September 2024, Getinge, a Sweden-based medical technology firm, acquired Paragonix Technologies for $253 million. This acquisition enables Getinge to enter the fast-growing organ preservation and transportation market, which is witnessing substantial growth driven by rising transplant volumes and technological advancements. Paragonix Technologies is a US-based biotechnology company specializing in organ preservation solutions.

Major companies operating in the organ preservation solution market include Bristol-Myers Squibb Company, Baxter International Inc., Accord Healthcare, BioLife Solutions Inc., Lifeline Scientific, TransMedics Group Inc., XVIVO Perfusion AB, Organ Recovery Systems Inc., Bridge to Life Ltd., Paragonix Technologies Inc., OrganOx Limited, Shanghai Genext Pharmaceutical Technology, 21st Century Medicine, Institut Georges Lopez, Carnamedica, Global Transplant Solutions, Preservation Solutions Inc., Essential Pharmaceuticals LLC, Dr. Franz Kohler Chemie GmbH, Advanced Organ Preservation Solutions (OPSL Group), Vascular Perfusion Solutions Inc., Transplant Biomedicals SL

North America was the largest region in the organ preservation solution market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organ Preservation Solution Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organ preservation solution market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for organ preservation solution ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The organ preservation solution market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Organ Preservation Solution Market Characteristics

3. Organ Preservation Solution Market Trends And Strategies

4. Organ Preservation Solution Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Organ Preservation Solution Growth Analysis And Strategic Analysis Framework

6. Organ Preservation Solution Market Segmentation

7. Organ Preservation Solution Market Regional And Country Analysis

8. Asia-Pacific Organ Preservation Solution Market

9. China Organ Preservation Solution Market

10. India Organ Preservation Solution Market

11. Japan Organ Preservation Solution Market

12. Australia Organ Preservation Solution Market

13. Indonesia Organ Preservation Solution Market

14. South Korea Organ Preservation Solution Market

15. Western Europe Organ Preservation Solution Market

16. UK Organ Preservation Solution Market

17. Germany Organ Preservation Solution Market

18. France Organ Preservation Solution Market

19. Italy Organ Preservation Solution Market

20. Spain Organ Preservation Solution Market

21. Eastern Europe Organ Preservation Solution Market

22. Russia Organ Preservation Solution Market

23. North America Organ Preservation Solution Market

24. USA Organ Preservation Solution Market

25. Canada Organ Preservation Solution Market

26. South America Organ Preservation Solution Market

27. Brazil Organ Preservation Solution Market

28. Middle East Organ Preservation Solution Market

29. Africa Organ Preservation Solution Market

30. Organ Preservation Solution Market Competitive Landscape And Company Profiles

31. Organ Preservation Solution Market Other Major And Innovative Companies

32. Global Organ Preservation Solution Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Organ Preservation Solution Market

34. Recent Developments In The Organ Preservation Solution Market

35. Organ Preservation Solution Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â